Connect with us

Healthcare

Rep. Louie Gohmert: ‘I Will Use Zinc, Erythromycin, and Hydroxychloroquine’ to Fight Coronavirus

Published

on

Rep Louie Gohmert

“My doctor and I are all in,” Rep. Louie Gohmert, R-Texas, told “Hannity” Wednesday while on quarantine from having contacted coronavirus. “And I got a text just before I came on from a dear friend, [a] doctor, who just found out he had it, and he said he started a HCQ [hydroxychloroquine] regimen, too.”

“So zinc, erythromycin, and hydroxychloroquine,” Gohmert added, “and that will start just in the next day or two.”

Gohmert explained that he found out he had coronavirus only when he was tested when he got invited to join President Trump on a trip to West Texas. “He [Trump] called me from Air Force One on the way home tonight and I said … ‘Mr. President, if you would not [have] invited me to go with you to West Texas, I would never have known I had the coronavirus,'” Gohmert said. “That’s what I got tested for it and then I found out I had it.”

Watch full interview with Sean Hannity on Fox News.

You may like

Continue Reading

Healthcare

TN Republican introduces legislation to fight opioid shipments into U.S.

Published

on

Fentanyl 1031234188 scaled

Tennessee Republican Representative Diana Harshbarger is attempting to fight the opioid crisis and epidemic through new legislation. Introduced Friday, Harshbarger told the Daily Caller:

The Daily Caller first obtained a copy of the legislation, which addresses what Harshbarger calls a “loophole.” The legislation amends the Controlled Substances Act to specifically require registrants to investigate reports of suspicious orders of controlled substances and halt them if necessary. Under the version of the act currently in force, drug manufacturers and distributors are only required to report suspicious orders of opioids and other controlled substances to the DEA.

“Breaking the opioid epidemic’s stranglehold on our nation is one of my foremost priorities. In an effort to do so, my colleagues and I have identified a loophole that allows distributors to continue order fulfillment, even under suspicious circumstances.”

“My bill closes that loophole with the requirements and guardrails needed to ensure these addictive and potentially dangerous drugs do not fall into the wrong hands while the DEA investigates. The future of our nation depends on us solving the addiction crisis, and this is a step towards that outcome” Harshbarger continued.

The Daily Caller reports:

According to a congressional report released in September, the opioid crisis cost the U.S. $1.5 trillion during the COVID-19 pandemic.

The CDC says 93,331 people died from overdoses in the U.S. in 2020, the highest in 50 years. Opioid-related deaths made up nearly three-quarters of the total.

Pharmaceutical companies have been blamed for contributing to the opioid epidemic. The Department of Justice is currently suing the pharmaceutical company AmerisourceBergen over allegations the company failed to report suspicious orders of opioids to federal law enforcement.

You may like

Continue Reading
Advertisement
-->

Trending Now

Advertisement
-->

Trending

Proudly Made In America | © 2022 M3 Media Management, LLC